La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Sisram Medical Performance dei guadagni passati

Il passato criteri di controllo 2/6

Sisram Medical ha registrato una crescita degli utili a un tasso medio annuo di 16.7%, mentre il settore Medical Equipment ha registrato utili in crescita a un tasso medio annuo di 12.4%. I ricavi sono stati in crescita a un tasso medio annuo di 21.4%. Il ritorno sul capitale proprio di Sisram Medical è 7% e ha margini netti di 8.8%.

Informazioni chiave

14.1%

Tasso di crescita degli utili

12.7%

Tasso di crescita dell'EPS

Medical Equipment Crescita del settore	13.7%
Tasso di crescita dei ricavi	19.8%
Rendimento del capitale proprio	5.8%
Margine netto	6.6%
Ultimo aggiornamento sui guadagni	30 Jun 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Aug 23

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Jul 24

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Jun 17

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

May 30

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Apr 19

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Mar 01

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Jan 12

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Dec 21

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Dec 01

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Oct 14

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Sep 28

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Aug 25

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Aug 01

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

May 19

Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

May 03

If You Like EPS Growth Then Check Out Sisram Medical (HKG:1696) Before It's Too Late

Apr 11

Sisram Medical (HKG:1696) Is Experiencing Growth In Returns On Capital

Mar 17

Is Now An Opportune Moment To Examine Sisram Medical Ltd (HKG:1696)?

Nov 22

Calculating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Aug 22

Be Wary Of Sisram Medical (HKG:1696) And Its Returns On Capital

Jul 27

Here's Why We Think Sisram Medical Ltd's (HKG:1696) CEO Compensation Looks Fair

Jun 24

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Apr 16

Ripartizione dei ricavi e delle spese

Come Sisram Medical guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

SEHK:1696 Ricavi, spese e utili (USD Millions )
Data	Ricavi	Guadagni	Spese G+A	Spese di R&S
30 Jun 24	356	24	165	17
31 Mar 24	358	28	162	17
31 Dec 23	359	31	159	18
30 Sep 23	355	35	150	18
30 Jun 23	352	38	141	19
31 Mar 23	353	39	135	18
31 Dec 22	354	40	129	18
30 Sep 22	349	38	126	17
30 Jun 22	344	35	123	16
31 Mar 22	319	33	112	16
31 Dec 21	294	31	101	16
30 Sep 21	255	28	86	15
30 Jun 21	216	24	70	14
31 Mar 21	189	19	65	13
31 Dec 20	162	13	59	11
30 Sep 20	161	13	59	11
30 Jun 20	160	13	59	10
31 Mar 20	167	17	59	10
31 Dec 19	174	21	59	10
30 Sep 19	167	22	56	8
30 Jun 19	161	24	52	6
31 Mar 19	158	23	50	6
31 Dec 18	154	22	47	6
30 Sep 18	151	18	46	7
30 Jun 18	149	14	45	9
31 Mar 18	143	12	43	9
31 Dec 17	137	11	40	9
30 Sep 17	131	11	37	9
30 Jun 17	126	10	34	9
31 Mar 17	123	11	35	8
31 Dec 16	118	8	31	7
31 Dec 15	110	8	30	7
31 Dec 14	101	6	27	7

Guadagni di qualità: 1696 ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di 1696 (8.8%) sono inferiori rispetto allo scorso anno (11.3%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di 1696 sono cresciuti del 16.7% all'anno negli ultimi 5 anni.

Accelerare la crescita: 1696 ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.

Guadagni vs Settore: 1696 ha avuto una crescita negativa degli utili ( -21.6% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Medical Equipment ( -8.3% ).

Sisram Medical Performance dei guadagni passati

Il passato criteri di controllo 2/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

Sisram Medical Ltd to Report First Half, 2024 Results on Aug 21, 2024

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Sisram Medical Ltd to Report Fiscal Year 2023 Results on Mar 20, 2024

First half 2023 earnings released: EPS: US$0.04 (vs US$0.044 in 1H 2022)

Full year 2022 earnings released: EPS: US$0.086 (vs US$0.069 in FY 2021)

Recent updates

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Dividend of HK$0.16 announced

Sisram Medical Ltd to Report First Half, 2024 Results on Aug 21, 2024

Sisram Medical Ltd Declares A Final Dividend, Payable on or Around 9 September 2024

Not Many Are Piling Into Sisram Medical Ltd (HKG:1696) Just Yet

Increases to CEO Compensation Might Be Put On Hold For Now at Sisram Medical Ltd (HKG:1696)

Sisram Medical Ltd, Annual General Meeting, Jun 24, 2024

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

Does Sisram Medical (HKG:1696) Have A Healthy Balance Sheet?

Full year 2023 earnings released: EPS: US$0.067 (vs US$0.086 in FY 2022)

Sisram Medical Ltd Announces Ordinary Final Cash Dividend for the Year Ended December 31, 2023

Sisram Medical Ltd to Report Fiscal Year 2023 Results on Mar 20, 2024

Estimating The Intrinsic Value Of Sisram Medical Ltd (HKG:1696)

Investor sentiment deteriorates as stock falls 20%

Now 21% overvalued

Take Care Before Diving Into The Deep End On Sisram Medical Ltd (HKG:1696)

Is Sisram Medical Ltd (HKG:1696) Potentially Undervalued?

Sisram Medical Ltd Announces the Registration Application of Profhilo

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Investor sentiment improves as stock rises 19%

Returns On Capital At Sisram Medical (HKG:1696) Have Stalled

At HK$6.71, Is It Time To Put Sisram Medical Ltd (HKG:1696) On Your Watch List?

First half 2023 earnings released: EPS: US$0.04 (vs US$0.044 in 1H 2022)

Upcoming dividend of HK$0.17 per share at 2.3% yield

Sisram Medical (HKG:1696) Is Paying Out A Larger Dividend Than Last Year

Sisram Medical Ltd Announces Final Ordinary Dividend for the Year Ended December 31, 2022, Payable 07 September 2023

Sisram Medical Announces the Launch of Alma Veil for the U.S. Market

Sisram Medical Ltd. Receives the Clearance from the U.S. Food and Drug Administration

Is There Now An Opportunity In Sisram Medical Ltd (HKG:1696)?

Investor sentiment improves as stock rises 16%

Sisram Medical (HKG:1696) Shareholders Will Want The ROCE Trajectory To Continue

Sisram Medical Ltd, Annual General Meeting, Jun 28, 2023

Is Sisram Medical (HKG:1696) Using Too Much Debt?

Investor sentiment improves as stock rises 18%

Full year 2022 earnings released: EPS: US$0.086 (vs US$0.069 in FY 2021)

Investor sentiment deteriorates as stock falls 16%

Is Now The Time To Look At Buying Sisram Medical Ltd (HKG:1696)?

Investor sentiment improves as stock rises 18%

Investor sentiment improves as stock rises 19%

Sisram Medical (HKG:1696) Could Be Struggling To Allocate Capital

Sisram Medical Ltd Announces Resignation of Mr. Guojun Bu from the Position of Executive Director of the Company with Effect from January 1, 2023

Investor sentiment improved over the past week

Sisram Medical (HKG:1696) Has A Rock Solid Balance Sheet

Investor sentiment improved over the past week

Should You Investigate Sisram Medical Ltd (HKG:1696) At HK$7.99?

Less than half of directors are independent

Investor sentiment improved over the past week

Some Investors May Be Worried About Sisram Medical's (HKG:1696) Returns On Capital

Investor sentiment deteriorated over the past week

Here's Why We Think Sisram Medical (HKG:1696) Is Well Worth Watching

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Sisram Medical Ltd Provides Revenue Guidance for the Year 2022

First half 2022 earnings released: EPS: US$0.044 (vs US$0.037 in 1H 2021)

Sisram Medical Ltd SHARE to Be Deleted from OTC Equity

Upcoming dividend of HK$0.16 per share

Sisram Medical Ltd to Report Q2, 2022 Results on Aug 19, 2022

Sisram Medical Ltd Declares Final Dividend for the Year Ended December 31, 2021, Payable on or Around 2 September 2022

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Investor sentiment deteriorated over the past week

Sisram Medical Ltd Announces Phase IIb Clinical Result on Submental Fat Reduction of JS-001

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Sisram Medical Ltd Announces Resignation of Yao WANG as Non-Executive Director

These 4 Measures Indicate That Sisram Medical (HKG:1696) Is Using Debt Safely

Is Sisram Medical Ltd (HKG:1696) Trading At A 29% Discount?

Full year 2021 earnings released: EPS: US$0.069 (vs US$0.03 in FY 2020)